清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Review article: irritable bowel syndrome: natural history, bowel habit stability and overlap with other gastrointestinal disorders

肠易激综合征 医学 便秘 自然史 内科学 卢比罗斯通 胃肠病学 入射(几何) 疾病 人口 胃肠道疾病 家族史 腹泻 慢性便秘 环境卫生 光学 物理
作者
Yamini Yadav,Guy D. Eslick,Nick Talley
出处
期刊:Alimentary Pharmacology & Therapeutics [Wiley]
卷期号:54 (S1) 被引量:3
标识
DOI:10.1111/apt.16624
摘要

Symptoms of irritable bowel syndrome (IBS) characteristically fluctuate over time. We aimed to review the natural history of IBS and IBS subgroups including bowel habit disturbances, and the overlap of IBS with other gastrointestinal disorders. The community incidence of IBS is approximately 67 per 1000 person years. The prevalence of IBS is stable over time because symptoms fluctuate and there is a portion who experience resolution of their GI symptoms similar in number to those developing new-onset IBS. The proportion who report resolution of symptoms varies amongst population-based studies from 17% to 55%. There is evidence of substantial movement between subtypes of IBS. For example in a clinical trial cohort, only one in four patients retained their baseline classification throughout the study periods, two in three moved between IBS-C (constipation) and IBS-M (mixed), while over half switched between IBS-D (diarrhoea) and IBS-M. The least stable group was IBS-M. There are very limited data on drivers of bowel habit change in IBS. There are emerging evidence fluctuations in intestinal immune activity might account for symptom variability over time. It is of clinical importance to recognise the substantial overlap of IBS symptoms with other gastrointestinal syndromes including gastro-oesophageal reflux disease. This is important to ensure the correct clinical diagnosis of IBS is made and patients are not over investigated. Knowledge of the natural history, stability of subgroups and overlap of IBS with other gastrointestinal conditions should be considered in therapeutic decision making.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
晕晕完成签到 ,获得积分10
3秒前
1分钟前
xiao发布了新的文献求助10
1分钟前
紫熊发布了新的文献求助10
1分钟前
悦耳冬萱完成签到 ,获得积分10
1分钟前
yhtsyy完成签到 ,获得积分10
2分钟前
开放的乐驹完成签到 ,获得积分10
2分钟前
wrl2023完成签到,获得积分10
2分钟前
xiao完成签到,获得积分10
3分钟前
斯文败类应助Douvei采纳,获得10
3分钟前
SciGPT应助科研通管家采纳,获得10
3分钟前
3分钟前
紫熊发布了新的文献求助10
3分钟前
3分钟前
Douvei发布了新的文献求助10
3分钟前
3分钟前
Douvei完成签到,获得积分10
3分钟前
慧子完成签到 ,获得积分10
3分钟前
紫熊发布了新的文献求助30
3分钟前
4分钟前
Nickky完成签到 ,获得积分10
4分钟前
紫熊发布了新的文献求助10
4分钟前
4分钟前
紫熊发布了新的文献求助30
5分钟前
Akim应助科研通管家采纳,获得10
5分钟前
SciGPT应助科研通管家采纳,获得10
5分钟前
FashionBoy应助sxmt123456789采纳,获得10
5分钟前
mystars完成签到,获得积分20
5分钟前
5分钟前
5分钟前
Qi完成签到 ,获得积分10
6分钟前
喜悦的小土豆完成签到 ,获得积分10
6分钟前
紫熊发布了新的文献求助30
6分钟前
老石完成签到 ,获得积分10
6分钟前
甘川完成签到 ,获得积分10
6分钟前
6分钟前
天宇发布了新的文献求助10
6分钟前
天宇完成签到,获得积分20
7分钟前
佳佳完成签到 ,获得积分10
7分钟前
紫熊发布了新的文献求助10
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6948533
求助须知:如何正确求助?哪些是违规求助? 8633274
关于积分的说明 18308042
捐赠科研通 6387765
什么是DOI,文献DOI怎么找? 3080908
关于科研通互助平台的介绍 2124270
邀请新用户注册赠送积分活动 2057795